LongeVC
Overview
LongeVC is a venture capital firm that invests in early-stage biotechnology and longevity-focused companies, supporting founders in therapeutics, diagnostics, and longevity infrastructure.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Turn Biotechnologies | Apr 2022 | Seed | Co-investor |
| Red Queen Bio | Nov 2025 | Seed | Co-investor |
| Valink Therapeutics | Oct 2025 | Series Pre-A | Co-investor |
| Catena Biosciences | Jun 2024 | Seed | Co-investor |
| Haut.AI | Nov 2023 | Seed | Lead |
For institutional investors. Book with your work email.
Key People
Sergey Jakimov
Managing Partner
Garri Zmudze
General Partner
Andrei Tereshchenko
Venture Partner
Artem A. Trotsyuk
Venture Partner
Matt Toner
Venture Partner
Pascal Schümperli
Venture Partner
Timothy E. Morris
Venture Partner
Vlad Cernouţan
Principal
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is LongeVC based?
LongeVC is headquartered in Washington D.C., United States.
When was LongeVC founded?
LongeVC was founded in 2020.
How many portfolio companies does LongeVC have?
LongeVC has 22 portfolio companies in Caplight's dataset.
What are some companies in LongeVC's portfolio?
Portfolio companies visible on Caplight include Turn Biotechnologies, Red Queen Bio, Valink Therapeutics, Catena Biosciences, Haut.AI.
What was LongeVC's most recent investment shown here?
LongeVC's most recent investment in this portfolio sample was in Red Queen Bio in 2025.
What sectors does LongeVC focus on?
LongeVC focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Media, Entertainment & Gaming, Frontier & Industrial Tech, Consumer & Commerce, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, Consumer & Commerce, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does LongeVC focus on?
LongeVC typically invests at the Early stage.
What is LongeVC's AUM?
LongeVC's assets under management are estimated between $35.0M and $40.0M.